Keybanc Maintains Overweight on Inspire Medical Systems, Raises Price Target to $335
Portfolio Pulse from richadhand@benzinga.com
Keybanc analyst Matthew Mishan maintains an Overweight rating on Inspire Medical Systems (NYSE:INSP) and raises the price target from $321 to $335.
June 08, 2023 | 1:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keybanc analyst maintains Overweight rating on Inspire Medical Systems (INSP) and raises price target from $321 to $335.
The news of Keybanc maintaining an Overweight rating and raising the price target for Inspire Medical Systems (INSP) from $321 to $335 indicates a positive outlook for the stock. This could lead to increased investor confidence and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100